Appropriate Safeguards and Article 89 of the GDPR: Considerations for Biobank, Databank and Genetic Research.
GDPR–general data protection regulation
biobank
consent
ethics review and governance
genetic research
safeguards
Journal
Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
06
2021
accepted:
03
01
2022
entrez:
7
3
2022
pubmed:
8
3
2022
medline:
8
3
2022
Statut:
epublish
Résumé
The collection and use of biological samples and data for genetic research, or for storage in a biobank or databank for future research, impacts upon many fundamental rights, including the right to dignity, the right to private and family life, the right to protection of personal data, the right to freedom of arts and sciences, and the right to non-discrimination. The use of genetic data and other health-related data in this context must be used in a manner that is rooted in human rights. Owing in part to the General Data Protection Regulation (GDPR) coming into force, the right to the protection of personal data in the context of scientific research has been afforded increasing attention. The GDPR gives effect to the right to data protection, but states that this right must be balanced against other rights and interests. The GDPR applies to all personal data, with specific attention to special categories of data, that includes health and genetic data. The collection, access to, and sharing of such data must comply with the GDPR, and therefore directly impacts the use of such data in research. The GDPR does provide for several derogations and exemptions for research from many of the strict processing requirements. Such derogations are permitted only if there are appropriate safeguards in place. Article 89 states that to be appropriate, safeguards must be "in accordance" with the GDPR "for the rights and freedoms of the data subject". In particular, those safeguards must ensure "respect for the principle of data minimisation". Despite the importance of safeguards, the GDPR is silent as to the specific measures that may be adopted to meet these requirements. This paper considers Article 89 and explores safeguards that may be deemed appropriate in the context of biobanks, databanks, and genetic research.
Identifiants
pubmed: 35251121
doi: 10.3389/fgene.2022.719317
pii: 719317
pmc: PMC8896881
doi:
Types de publication
Journal Article
Langues
eng
Pagination
719317Informations de copyright
Copyright © 2022 Staunton, Slokenberga, Parziale and Mascalzoni.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Annu Rev Genomics Hum Genet. 2016 Aug 31;17:375-93
pubmed: 26905784
J Med Genet. 2019 Mar;56(3):176-185
pubmed: 30464052
Eur J Hum Genet. 2019 Aug;27(8):1159-1167
pubmed: 30996335
Eur J Hum Genet. 2020 May;28(5):609-626
pubmed: 31844175
Hastings Cent Rep. 2014 Jul-Aug;44(4):33-4
pubmed: 25043364
BMC Med Ethics. 2015 Apr 12;16:24
pubmed: 25889051
Eur J Hum Genet. 2015 Feb;23(2):141-6
pubmed: 24801761
Med Health Care Philos. 2022 Mar;25(1):23-30
pubmed: 34787769
PeerJ. 2016 Feb 25;4:e1613
pubmed: 26966643
Public Health Genomics. 2011;14(2):104-14
pubmed: 20689244
Life Sci Soc Policy. 2020 Jan 6;16(1):1
pubmed: 31903508